Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q1

4078.TEDINET S100RJIK
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥21.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥83.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥21.4bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥932m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.8bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥926m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥4.6bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥878m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥2.6bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥454m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥565m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥131.4bnat 2023-06-30Cons.Assets
Total assets¥128.0bnat 2023-03-31Cons.Assets
Total assets¥127.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥45.9bnat 2023-06-30Cons.Liabilities
Total liabilities¥43.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥85.5bnat 2023-06-30Cons.Net assets
Net assets / equity¥84.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥84.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥14.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥12.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥28.042023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥109.42022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.642023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio61.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥302m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥302m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥569m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2023-04-01 → 2023-06-30¥19.3bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2023-04-01 → 2023-06-30¥19.1bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥247m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2023-04-01 → 2023-06-30¥2.0bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2023-04-01 → 2023-06-30¥2.0bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥54m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2023-04-01 → 2023-06-30¥60m
—segment totalrevenue2023-04-01 → 2023-06-30¥21.4bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥21.1bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥302m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥558m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-06-30¥19.8bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-06-30¥19.5bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥360m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.3bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥74m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-06-30¥89m
—segment totalrevenue2022-04-01 → 2022-06-30¥21.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥21.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥435m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 367
ItemContextValueUnit
Remeasurements of defined benefit plansPrior1YearInstant117000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant113000000JPY
Valuation and translation adjustmentsPrior1YearInstant1624000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant2270000000JPY
Subscription rights to sharesPrior1YearInstant－JPY
Subscription rights to sharesCurrentQuarterInstant35000000JPY
Non controlling interestsPrior1YearInstant4229000000JPY
Non controlling interestsCurrentQuarterInstant4334000000JPY
Net assetsPrior1YearInstant84717000000JPY
Net assetsCurrentQuarterInstant85471000000JPY
Liabilities and net assetsPrior1YearInstant128021000000JPY
Liabilities and net assetsCurrentQuarterInstant131410000000JPY
Net salesPrior1YTDDuration21400000000JPY
Net salesCurrentYTDDuration21086000000JPY
Cost of salesPrior1YTDDuration16010000000JPY
Cost of salesCurrentYTDDuration16664000000JPY
Gross profitPrior1YTDDuration5390000000JPY
Gross profitCurrentYTDDuration4421000000JPY
Selling general and administrative expensesPrior1YTDDuration3563000000JPY
Selling general and administrative expensesCurrentYTDDuration3489000000JPY
Operating incomePrior1YTDDuration1826000000JPY
Operating incomeCurrentYTDDuration932000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration1000000JPY
Dividends income noiPrior1YTDDuration86000000JPY
Dividends income noiCurrentYTDDuration72000000JPY
Foreign exchange gains noiPrior1YTDDuration221000000JPY
Foreign exchange gains noiCurrentYTDDuration135000000JPY
Other noiPrior1YTDDuration25000000JPY
Other noiCurrentYTDDuration14000000JPY
Non operating incomePrior1YTDDuration333000000JPY
Non operating incomeCurrentYTDDuration223000000JPY
Interest expenses noePrior1YTDDuration17000000JPY
Interest expenses noeCurrentYTDDuration21000000JPY
Tender offer related expenses noePrior1YTDDuration－JPY
Tender offer related expenses noeCurrentYTDDuration194000000JPY
Other noePrior1YTDDuration18000000JPY
Other noeCurrentYTDDuration13000000JPY
Non operating expensesPrior1YTDDuration35000000JPY
Non operating expensesCurrentYTDDuration229000000JPY
Ordinary incomePrior1YTDDuration2125000000JPY
Ordinary incomeCurrentYTDDuration926000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration70000000JPY
Gain on sales of investment securities eiCurrentYTDDuration42000000JPY
Gain on sales of golf memberships eiPrior1YTDDuration1000000JPY
Gain on sales of golf memberships eiCurrentYTDDuration－JPY
Insurance income eiPrior1YTDDuration380000000JPY
Insurance income eiCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass